This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Thymidylate Synthase

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Thymidylate Synthase Means in Everyday Medical Language

Thymidylate synthase is a protein inside cells that helps make and repair DNA, the molecule that carries genetic information. DNA is essential for cells to grow and divide properly. This enzyme specifically helps produce one of the building blocks of DNA called thymidine. Without thymidylate synthase, cells cannot make new DNA correctly, which affects their ability to multiply.

Why Thymidylate Synthase Can Matter in Cancer Care

In some types of cancer, thymidylate synthase is found at higher levels. This may influence how the cancer grows and how it responds to treatments. Because cancer cells rely on making DNA to multiply quickly, blocking thymidylate synthase can slow or stop their growth. This is why certain chemotherapy drugs, called thymidylate synthase inhibitors, are used to target this enzyme. These drugs interfere with the cancer cells’ ability to make DNA, which can help control the cancer.

What Patients Might See or Hear About Thymidylate Synthase

You might see the term thymidylate synthase in medical reports, treatment plans, or discussions about cancer drugs. Sometimes it appears alongside names of drugs like 5-fluorouracil, raltitrexed (also called ICI D1694), or experimental drugs such as AG337 (nolatrexed or Thymitaq). These drugs belong to the group of thymidylate synthase inhibitors. Seeing these terms does not mean a specific diagnosis or treatment is decided. It’s important to ask your care team how these terms relate to your individual care.

How Doctors Use Thymidylate Synthase in Cancer Treatment

Doctors may test for levels of thymidylate synthase to help understand how a cancer might behave or respond to certain treatments. For example, lower levels of this enzyme in some cancers have been linked to better responses to drugs like 5-fluorouracil. However, this is not always the case, and the role of thymidylate synthase can vary depending on the type of cancer. Treatments that block this enzyme are part of chemotherapy plans for cancers such as colorectal, liver, pancreatic, ovarian, gastric, and breast cancers. Experimental drugs targeting thymidylate synthase are also being studied in clinical trials.

Common Questions to Ask Your Care Team

If you encounter the term thymidylate synthase or related drug names, you might ask: What does this mean for my cancer? Is this enzyme being tested in my case? Are thymidylate synthase inhibitors part of my treatment options? What are the possible benefits and side effects? Are there clinical trials involving these drugs that I could consider? Understanding how this enzyme and its inhibitors fit into your care can help you feel more informed and involved.

How to Read the Term in Context

Thymidylate synthase is a scientific term that by itself does not provide a diagnosis or treatment plan. It is best understood as part of a larger discussion about your cancer and treatment options. Always ask your healthcare team to explain what it means in your specific medical reports or treatment plans. Avoid making assumptions based on the word alone.

Safety and Next Steps

This information is meant to help you understand cancer-related terms and should not replace personalized medical advice. If thymidylate synthase or related drugs are mentioned in your care, the safest next step is to talk with your healthcare team. They can explain what it means for you personally and help guide your treatment decisions based on your unique situation.

Sources

Public source information used for this glossary entry includes: